The adrenal insufficiency treatment market is expanding as demand increases for glucocorticoid and mineralocorticoid replacement therapies, enhanced diagnostic screening, and patient monitoring technologies in both adult and pediatric settings. https://www.datamintelligence.com/research-report/heparin-induced-thrombocytopenia-market